Atul
- P/E
- 19.67
Key Fundamentals
SmallcapChemicals & PetrochemicalsChemicalsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 14.90%
- Debt to Equity
- 0.03
- EPS (TTM)
- ₹262.19
- Book Value
- ₹2,235.96
- Market Cap
- —
- P/E (TTM)
- 19.67
- P/B
- 2.31
- ROE
- 11.50%
- Dividend Yield
- 0.59%
- EBITDA
- ₹1,234 Cr
- 52W High
- ₹7,180.00
- 52W Low
- ₹4,995.00
- Day Range
- ₹5,018.00 – ₹5,175.00
- Volume
- 65,899
Peer Comparison
Commodities › Chemicals › Specialty Chemicals
| ₹1,510.20 | 58.04 | ₹1,54,107 Cr | 13.72 | 1.42% | 23.90% | 31.00% | ₹15,399 Cr | ₹2,677 Cr | |
| ₹4,613.30 | 83.76 | ₹49,073 Cr | 6.04 | 0.07% | 7.82% | 9.64% | ₹5,303 Cr | ₹600 Cr | |
| ₹8,785.00 | 57.03 | ₹44,060 Cr | 10.10 | 0.09% | 19.60% | 21.00% | ₹3,634 Cr | ₹789 Cr | |
| ₹1,578.40 | 27.48 | ₹20,919 Cr | 3.32 | 0.49% | 9.82% | 11.40% | ₹8,575 Cr | ₹784 Cr | |
| ₹1,540.70 | 86.90 | ₹20,030 Cr | 7.88 | 0.00% | 9.66% | 11.90% | ₹1,231 Cr | ₹235 Cr | |
| ₹447.55 | 30.57 | ₹15,838 Cr | 2.59 | 0.23% | 7.13% | 6.86% | ₹9,010 Cr | ₹531 Cr | |
| ₹5,156.50 | 19.67 | ₹14,827 Cr | 2.31 | 0.59% | 11.50% | 14.90% | ₹6,969 Cr | ₹788 Cr | |
| Median 7 companies | ₹1,578.40 | 57.03 | ₹20,919 Cr | 6.04 | 0.23% | 9.82% | 11.90% | ₹6,969 Cr | ₹784 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 61
- Good
- Returns, margins, earnings quality 22% weight
- Valuation
- 65
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 61
- Good
- Sales & profit trajectory 9% weight
- Financial Health
- 82
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 13
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 51
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is almost debt free.
Weaknesses
2- The company has delivered a poor sales growth of 11.0% over past five years.
- Company has a low return on equity of 9.23% over last 3 years.
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bearish | 12 | 3 | 4 |
| Oscillators | Bullish | 2 | 3 | 4 |
| Moving Averages | Strong Bearish | 10 | 0 | 0 |
Oscillators
Bullish
Overall
Strong Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 28.75
- Bullish
- MACD (12,26,9)
- −278.58
- Bearish
- SMA (50)
- 6,001.20
- Bearish
- SMA (200)
- 6,384.48
- Bearish
As of
Analyst Rating
8 of 11 analysts rate Buy, 2 Hold, 1 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Sep 2026 against Sep 2025.
Revenue
| 10Y | +9.23% |
|---|---|
| 5Y | +10.95% |
| 3Y | +4.95% |
| 1Y | +12.38% |
| TTM | +18.14% |
Net profit
| 10Y | +9.66% |
|---|---|
| 5Y | +0.86% |
| 3Y | +10.77% |
| 1Y | +38.08% |
| TTM | +40.46% |
Operating cash flow
| 10Y | +9.82% |
|---|---|
| 5Y | +7.34% |
| 3Y | +13.11% |
| 1Y | +69.65% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | −1.28 pp |
|---|---|
| 5Y | −8.12 pp |
| 3Y | +1.61 pp |
| 1Y | +0.04 pp |
| TTM | +0.67 pp |
Revenue by year
| Mar 2017 | ₹2,834 Cr |
|---|---|
| Mar 2018 | ₹3,514 Cr |
| Mar 2019 | ₹4,038 Cr |
| Mar 2020 | ₹4,093 Cr |
| Mar 2021 | ₹3,731 Cr |
| Mar 2022 | ₹5,081 Cr |
| Mar 2023 | ₹5,428 Cr |
| Mar 2024 | ₹4,726 Cr |
| Mar 2025 | ₹5,583 Cr |
| Mar 2026 | ₹6,274 Cr |
Net profit by year
| Mar 2017 | ₹323 Cr |
|---|---|
| Mar 2018 | ₹281 Cr |
| Mar 2019 | ₹436 Cr |
| Mar 2020 | ₹671 Cr |
| Mar 2021 | ₹660 Cr |
| Mar 2022 | ₹605 Cr |
| Mar 2023 | ₹507 Cr |
| Mar 2024 | ₹324 Cr |
| Mar 2025 | ₹499 Cr |
| Mar 2026 | ₹689 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Atul Ltd trades at ₹5,028.50 as of 2026-10-30 with a market cap of ₹14,804.79 Cr and a PE of 19.18x on TTM EPS of ₹262.19. The company is virtually debt-free (D/E of 0.03) and has posted strong TTM profit growth of 42%, though its stock has delivered negative returns over 1-year (-5%), 3-year (-4%), and 5-year (-10%) CAGR periods.
- Near-zero leverage with a debt-to-equity ratio of just 0.03, providing significant financial flexibility and resilience through commodity cycles.
- TTM compounded profit growth of 42% signals a sharp earnings recovery and potential operating leverage kicking in.
- TTM sales growth of 18% marks a meaningful acceleration versus the 5-year compounded sales CAGR of 11% and 3-year CAGR of 5%.
- Trading near its 52-week low of ₹4,995 (current price ₹5,028.50 versus 52-week high of ₹7,180), the stock is 30% off its highs, compressing valuation multiples.
- ROE has improved to 10.95% (last year 11%) from the 3-year average of 9%, indicating improving capital efficiency.
- PE of 19.18x is reasonable for a specialty chemicals company with a near-debt-free balance sheet and accelerating earnings growth.
- 10-year compounded sales and profit CAGR of 9% each, alongside a 10-year stock CAGR of 9%, demonstrate long-term business consistency.
- ROCE of 13.54% comfortably exceeds cost of capital for a virtually unleveraged business, reflecting productive asset deployment.
- 5-year compounded sales growth of only 11% is considered poor for the specialty chemicals sector, suggesting limited top-line momentum over a sustained period.
- Stock CAGR is negative across all medium-term horizons: -5% over 1 year, -4% over 3 years, and -10% over 5 years, indicating persistent value erosion for shareholders.
- 3-year average ROE of just 9% is low for a capital-intensive chemicals business and trails the 10-year average of 13%, pointing to a structural decline in profitability.
- 5-year compounded profit CAGR of only 1% suggests the strong TTM profit growth of 42% may be a low-base recovery rather than a sustainable trend.
- Price-to-book of 2.25x on an ROE of 10.95% implies the market is pricing in improvement that has yet to be sustained over multiple years.
- 10-year ROE trend has declined from 13% to the current 10.95%, suggesting diminishing return on incremental capital deployed over time.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Atul Ltd's ongoing ₹90 crore buyback provides a floor of capital-return support, but only ~12% has been utilised through three days. The 10.6% YoY drop in Q2FY27 net profit flags earnings softness. With limited recent newsflow, the near-term trajectory hinges on whether upcoming quarters show margin recovery or further deterioration.
- Q2FY27 net profit drops 10.6% Nov 04
Atul Ltd reported Q2FY27 net profit of ₹158.71 crore, down 10.6% YoY, signalling near-term earnings pressure.
- Buyback utilisation still early Nov 04
Atul Ltd bought back 4,100 shares at avg ₹5,094.70 on Nov 4 (day three), with cumulative 21,200 shares purchased for ₹10.82 crore of the ₹90 crore earmarked — just 12% utilised so far.
Quarterly Results
₹ Cr| Particulars | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,194 | 1,138 | 1,212 | 1,322 | 1,393 | 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 | 1,877 |
| Expenses | 1,039 | 986 | 1,065 | 1,099 | 1,150 | 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 | 1,454 | 1,630 |
| Operating Profit | 155 | 152 | 148 | 223 | 243 | 224 | 223 | 236 | 267 | 247 | 281 | 394 | 247 |
| OPM % | 13% | 13% | 12% | 17% | 17% | 16% | 15% | 16% | 17% | 16% | 17% | 21% | 13% |
| Other Income | 24 | 15 | 16 | 16 | 35 | 19 | 48.7 | 26.24 | 48.5 | 38.59 | 89.57 | 35 | 48.4 |
| Interest | 2 | 2 | 5 | 5 | 9 | 4 | 5 | 5 | 5 | 4 | 4 | 4 | 4 |
| Depreciation | 54 | 61 | 76 | 77 | 78 | 81 | 82 | 82 | 81 | 80 | 79 | 78 | 78 |
| PBT | 124 | 105 | 83 | 158 | 191 | 158 | 185 | 175 | 230 | 203 | 289 | 347 | 214 |
| Tax % | 26% | 32% | 29% | 29% | 27% | 26% | 30% | 25% | 21% | 20% | 27% | 27% | 26% |
| Net Profit | 91 | 72 | 59 | 112 | 140 | 117 | 130 | 132 | 182 | 164 | 211 | 254 | 159 |
| EPS (₹) | 30.6 | 24.04 | 19.84 | 38 | 46.47 | 36.93 | 42.97 | 43.4 | 60.88 | 54.6 | 71.38 | 83.32 | 52.89 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,637 | 2,595 | 2,834 | 3,514 | 4,038 | 4,093 | 3,731 | 5,081 | 5,428 | 4,726 | 5,583 | 6,274 | 6,969 |
| Expenses | 2,235 | 2,134 | 2,324 | 3,008 | 3,270 | 3,191 | 2,813 | 4,168 | 4,620 | 4,086 | 4,665 | 5,240 | 5,801 |
| Operating Profit | 402 | 461 | 510 | 505 | 768 | 902 | 918 | 913 | 807 | 639 | 918 | 1,034 | 1,168 |
| OPM % | 15% | 18% | 18% | 14% | 19% | 22% | 25% | 18% | 15% | 14% | 16% | 16% | 17% |
| Other Income | 9 | 37 | 57 | 30 | 38 | 83 | 109 | 82 | 86 | 65 | 115 | 206 | 217 |
| Interest | 26 | 28 | 25 | 13 | 7 | 9 | 9 | 9 | 8 | 11 | 24 | 17 | 16 |
| Depreciation | 60 | 66 | 95 | 110 | 119 | 130 | 136 | 177 | 198 | 243 | 317 | 322 | 315 |
| PBT | 326 | 404 | 446 | 412 | 680 | 845 | 882 | 810 | 688 | 451 | 692 | 900 | 1,053 |
| Tax % | 31% | 32% | 28% | 32% | 36% | 21% | 25% | 25% | 26% | 28% | 28% | 23% | — |
| Net Profit | 240 | 274 | 323 | 281 | 436 | 671 | 660 | 605 | 507 | 324 | 499 | 689 | 787 |
| EPS (₹) | 81.13 | 92.44 | 109 | 93.21 | 146 | 225 | 222 | 204 | 174 | 110 | 164 | 230 | 262 |
| Div. Payout % | 10% | 9% | 9% | 13% | 10% | 12% | 9% | 12% | 19% | 18% | 15% | 13% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | Sep 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 30 | 29 | 29 | 29 | 29 |
| Reserves | 1,009 | 1,585 | 1,936 | 2,214 | 2,676 | 3,125 | 3,797 | 4,399 | 4,642 | 5,085 | 5,569 | 6,192 | 6,554 |
| Borrowings | 299 | 316 | 168 | 16 | 55 | 108 | 127 | 144 | 52 | 237 | 202 | 183 | 169 |
| Other Liabilities | 485 | 535 | 591 | 749 | 783 | 880 | 982 | 1,117 | 1,028 | 1,104 | 1,179 | 1,465 | 1,666 |
| Total Liabilities | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 | 8,418 |
| Fixed Assets | 514 | 750 | 1,026 | 1,027 | 1,104 | 1,125 | 1,418 | 1,634 | 1,770 | 2,792 | 2,847 | 2,676 | 2,656 |
| CWIP | 112 | 180 | 59 | 96 | 172 | 368 | 250 | 420 | 1,033 | 281 | 124 | 110 | 122 |
| Investments | 66 | 382 | 429 | 470 | 752 | 1,137 | 1,361 | 1,339 | 881 | 1,392 | 1,766 | 2,592 | 2,808 |
| Other Assets | 1,131 | 1,154 | 1,210 | 1,415 | 1,515 | 1,513 | 1,906 | 2,297 | 2,068 | 1,990 | 2,242 | 2,492 | 2,833 |
| Total Assets | 1,823 | 2,465 | 2,724 | 3,009 | 3,543 | 4,144 | 4,935 | 5,690 | 5,752 | 6,455 | 6,980 | 7,870 | 8,418 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 306 | 401 | 392 | 356 | 404 | 881 | 718 | 231 | 707 | 667 | 603 | 1,023 |
| Investing | −167 | −375 | −175 | −129 | −408 | −782 | −645 | −163 | −469 | −683 | −494 | −891 |
| Financing | −124 | −39 | −212 | −207 | −1 | −111 | −52 | −57 | −257 | 38 | −118 | −98 |
| Net Cash Flow | 16 | −13 | 5 | 19 | −5 | −11 | 21 | 11 | −20 | 22 | −9 | 34 |
| Free Cash Flow | 111 | 31 | 180 | 213 | 195 | 508 | 396 | −359 | −167 | 164 | 334 | 851 |
| CFO/EBITDA | 95 | 111 | 93 | 91 | 86 | 122 | 100 | 47 | 112 | 121 | 82 | 113 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 61 | 62 | 67 | 75 | 63 | 64 | 72 | 71 | 57 | 72 | 74 | 74 |
| Inventory Days | 105 | 118 | 107 | 83 | 89 | 93 | 128 | 122 | 101 | 90 | 97 | 90 |
| Days Payable | 69 | 87 | 86 | 93 | 66 | 88 | 121 | 90 | 69 | 84 | 82 | 94 |
| Cash Conversion Cycle | 97 | 93 | 88 | 66 | 86 | 69 | 78 | 103 | 89 | 77 | 89 | 70 |
| Working Capital Days | 50 | 46 | 65 | 76 | 74 | 59 | 65 | 77 | 68 | 69 | 77 | 69 |
| ROCE % | 26% | 26% | 23% | 19% | 27% | 28% | 24% | 19% | 15% | 9% | 13% | 15% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Atul insights
67 extracted metrics across FY04–FY27.
Documents
- 23 Oct 2026
- 24 Jul 2026
- 24 Apr 2026
- 7 Oct 2026
- 1 Oct 2025
- 10 Oct 2024
- 24 Aug 2023
- 3 Aug 2022
- General announcements 3 Nov 2026
- General announcements 2 Nov 2026
- General announcements 2 Nov 2026
- General announcements 27 Oct 2026
Frequently Asked Questions about Atul
What does Atul Ltd do?
Where is Atul Ltd (ATUL) listed?
Which sector does Atul Ltd belong to?
What is the PE ratio of Atul Ltd?
What is the 52-week high and low of Atul Ltd?
Does Atul Ltd pay dividends?
What is the Return on Equity (ROE) of Atul Ltd?
Company Information
Atul Ltd. is a diversified and integrated Indian chemical company (a part of Lalbhai Group, Gujarat). The products of the company are used in various Industries and come mainly under two segments, Life Science Chemicals and Performance and Other Chemicals under 9 Businesses. Since its incorporation, the company has manufactured many products for the first time in India Dyes including Vat Dyes, crop care chemicals, Phosgene, Carbamite, 2,4-D Acid, para Cresol, tissue culture raised date palms.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/ATUL.md for Atul Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.